-
Electronic (PDF)
-
Site License
-
Enterprisewide
BioDiem Ltd (BDM) - Financial and Strategic SWOT Analysis Review
GlobalData, March 2013, Pages: 34
Summary
BioDiem Ltd. (BioDiem) is a biotechnology company. The company carries out the discovery, development and commercialization of vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company possesses Live Attenuated Influenza Virus (LAIV) technology, the SAVINE platform and two synthetic compounds, namely, BDM-E and BDM-I. LAIV technology is used for the development of a novel intranasal vaccine for pandemic and seasonal influenza.
This comprehensive SWOT profile of BioDiem Ltd provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
List of Tables
List of Figures
Section 1 - About the Company
BioDiem Ltd - Key Facts
BioDiem Ltd - Key Employees
BioDiem Ltd - Key Employee Biographies
BioDiem Ltd - Key Operational Employees
BioDiem Ltd - Major Products and Services
BioDiem Ltd - Pharmaceutical Pipeline Products Data
BioDiem Ltd, Pipeline Products by Therapy Area
BioDiem Ltd, Pipeline Products by Development Phase
BioDiem Ltd - History
BioDiem Ltd - Company Statement
BioDiem Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
BioDiem Ltd - Business Description
BioDiem Ltd - Corporate Strategy
BioDiem Ltd - SWOT Analysis
SWOT Analysis - Overview
BioDiem Ltd - Strengths
Strength - LAIV Technology
Strength - Strong Research and Development Capabilities
Strength - Recognition by WHO
BioDiem Ltd - Weaknesses
Weakness - History of Losses
BioDiem Ltd - Opportunities
Opportunity - Partnerships and Collaborations
Opportunity - Emerging Markets
Opportunity - Changing Demographics
BioDiem Ltd - Threats
Threat - Competition
Threat - Industry Consolidation
Threat - Uncertain R&D Outcomes
BioDiem Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
BioDiem Ltd, Recent Deals Summary
Section 5 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
BioDiem Ltd, Key Facts
BioDiem Ltd, Key Employees
BioDiem Ltd, Key Employee Biographies
BioDiem Ltd, Key Operational Employees
BioDiem Ltd, Major Products and Services
BioDiem Ltd, Number of Pipeline Products by Therapy Area
BioDiem Ltd, Number of Pipeline Products by Development Stage
BioDiem Ltd, Pipeline Products By Therapy Area and Development Phase
BioDiem Ltd, History
BioDiem Ltd, Subsidiaries
BioDiem Ltd, Key Competitors
BioDiem Ltd, Ratios based on current share price
BioDiem Ltd, Annual Ratios
BioDiem Ltd, Interim Ratios
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
BioDiem Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
BioDiem Ltd, Pipeline Products by Therapy Area
BioDiem Ltd, Pipeline Products by Development Phase
BioDiem Ltd, Performance Chart (2008 - 2012)
BioDiem Ltd, Ratio Charts
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
AdAlta Pty Ltd.
Solagran Ltd.
Prima BioMed Limited
Aft Pharmaceuticals Pty Ltd
AusBiotech Ltd
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
